American Cannabis Co (American Cannabis Co) Cash Flow from Financing : $0.02 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is American Cannabis Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2023, American Cannabis Co paid $0.00 Mil more to buy back shares than it received from issuing new shares. It spent $0.28 Mil paying down its debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.03 Mil on other financial activities. In all, American Cannabis Co spent $0.25 Mil on financial activities for the three months ended in Dec. 2023.

American Cannabis Co Cash Flow from Financing Historical Data

The historical data trend for American Cannabis Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cannabis Co Cash Flow from Financing Chart

American Cannabis Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Financing

Get a 7-Day Free Trial

1.30

1.37

-0.25

0.02

American Cannabis Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow from Financing	Get a 7-Day Free Trial															0.18	0.19	-0.37	0.45	-0.25

American Cannabis Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

American Cannabis Co's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

	Cash Flow from Financing		(A: Dec. 2023 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	-0.015	+	0	+	0	+	0.03
=	0.02

American Cannabis Co's Cash from Financing for the quarter that ended in Dec. 2023 is:

	Cash Flow from Financing		(Q: Dec. 2023 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	-0.275	+	0	+	0	+	0.029
=	-0.25

Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

American Cannabis Co (OTCPK:AMMJ) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

American Cannabis Co's issuance of stock for the three months ended in Dec. 2023 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

American Cannabis Co's repurchase of stock for the three months ended in Dec. 2023 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

American Cannabis Co's net issuance of debt for the three months ended in Dec. 2023 was $-0.28 Mil. American Cannabis Co spent $0.28 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

American Cannabis Co's net issuance of preferred for the three months ended in Dec. 2023 was $0.00 Mil. American Cannabis Co paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

American Cannabis Co's cash flow for dividends for the three months ended in Dec. 2023 was $0.00 Mil. American Cannabis Co received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

American Cannabis Co's other financing for the three months ended in Dec. 2023 was $0.03 Mil. American Cannabis Co received $0.03 Mil on other financial activities.

American Cannabis Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of American Cannabis Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

American Cannabis Co (American Cannabis Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » American Cannabis Co Inc (OTCPK:AMMJ) » Definitions » Cash Flow from Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Union Street, Suite 200, Lakewood, CO, USA, 80228

Website

https://www.americancannabisconsulting.com

American Cannabis Co Inc is engaged in the cannabis industry in states and countries where cannabis is regulated and/or has been decriminalized for medical use and/or legalized for recreational use. It provides advisory and consulting services specific to this industry, designs industry-specific products and facilities, and manages a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. It also is a licensed operator of three medical cannabis dispensaries and a cannabis cultivation facility in Colorado Springs, CO.

Executives

Tyler A Schloesser	officer: Chief Operations Officer	9874 WEST LA SALLE PLACE, LAKEWOOD CO 80227
Ellis Lamar Smith	director, 10 percent owner, officer: Cheif Development Officer	2590 WALNUT ST, DENVER CO 80205
Hollister Corey James Ariel	director, 10 percent owner, officer: Chief Executive Officer	5316 RUSTIC AVE, FIRESTONE CO 80504
David Michael Godfrey	officer: Principal Accounting Officer	5690 LOGAN STREET, DENVER CO 80237
Jon Workman	officer: Vice President	2600 RAY DEAN ROAD, TUCKER AR 72168
Michael Schwanbeck	officer: Chief Financial Officer	555 E. 19TH AVENUE, #2421, DENVER CO 80203
Tad M Mailander	director	4811 49TH STREET, SAN DIEGO CA 92115
Terry Lynn Buffalo	director, officer: CEO	3063 BRIGHTON BLVD, #918, DENVER CO 80216
Jesus Quintero	officer: Former CFO	16860 SOUTHWEST 1ST STREET, PEMBROKE PINES FL 33027
Michael A Novielli	director, 10 percent owner	100 MILL PLAIN ROAD, 3RD FLOOR, DANBURY CT 06811
Anthony J Baroud	director, 10 percent owner, officer: Chief Technology Officer	211 EAST CIRCLE AVE, PROSPECT HEIGHTS IL 60070
Themistocles Psomiadis	director, officer: Chief Executive Officer	1420 MIDTOWN AVE, APT 407, MOUNT PLEASANT SC 29464
Villas Boas Andrea Bezerra Arruda	10 percent owner	ALAMEDA UAPIXANA, 278, SAO PAULO D5 04085-030
Douglas Leighton	director	312 STUART ST, BOSTON MA 02116
Donald Brucker	director, 10 percent owner, officer: VP Research & Development	110 WEST C STREET, SUITE 1300, SAN DIEGO CA 92101